Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Concord Medical CoROCO:6518 -0.65%71 EV-to-FCF is 7.74 as of Jul. 30, 2026, which is 16% above its 10-year median of 6.66. GuruFocus rates ROCO:6518 with a GF Score™ of 71/100 and a GF Value™ of NT$29.15 (Fairly Valued). The stock has 3 warning signs investors should review. Among 417 Medical Devices & Instruments companies, Concord Medical Co ranks better than 86.33% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Concord Medical Co's Enterprise Value is NT$943.6 Mil.
Concord Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$121.9 Mil. Therefore, Concord Medical Co's EV-to-FCF for today is 7.74.
The historical rank and industry rank for Concord Medical Co's EV-to-FCF or its related term are showing as below:
ROCO:6518'
s EV-to-FCF Range Over the Past 10 Years
Min: -208.6 Med: 6.66 Max: 34.58
Current: 8.05
During the past 13 years, the highest EV-to-FCF of Concord Medical Co was 34.58. The lowest was -208.60. And the median was 6.66.
ROCO:6518's EV-to-FCF is ranked better than 86.33% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.7
vs ROCO:6518: 8.05
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Concord Medical Co (ROCO:6518) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Concord Medical Co's PE Ratio (TTM) for today is calculated as:
Concord Medical Co's share price for today is NT$30.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Concord Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$2.010.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Concord Medical Co EV-to-FCF Related Terms
Concord Medical Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Concord Medical Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6518 vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, Concord Medical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Concord Medical Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Concord Medical Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Concord Medical Co's EV-to-FCF falls into.
Concord Medical Co's current Enterprise Value is NT$943.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Concord Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$121.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Concord Medical Co (ROCO:6518) has a EV-to-FCF of 7.74 as of Jul. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Concord Medical Co and its competitors. This is 16% above median its historical median of 6.66. According to the industry distribution chart, Concord Medical Co ranks #57 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 13.7%.
Is Concord Medical Co's EV-to-FCF too high?
Concord Medical Co's current EV-to-FCF of 7.74 is 16% above median its 10-year median of 6.66. The Medical Devices & Instruments industry median EV-to-FCF is 23.70. Concord Medical Co's value of 7.74 is 67.3% below this industry median. Based on the distribution chart, Concord Medical Co ranks #57 out of 417 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Concord Medical Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Concord Medical Co's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Concord Medical Co ranks #57 out of 417 companies for EV-to-FCF. This places Concord Medical Co in the top 14% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 23.70. Concord Medical Co's value of 7.74 is 67.3% below this benchmark. While the company's 10-year median is 6.66 vs. the industry median of 23.70, Concord Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.70, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Concord Medical Co's current EV-to-FCF of 7.74 is 67.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Concord Medical Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Concord Medical Co's current EV-to-FCF is 7.74, which is 16% above median its own 10-year median of 6.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Concord Medical Co (ROCO:6518) is currently considered Fairly Valued. The stock's GF Value™ is NT$29.15, compared to a current price of NT$30.40 — trading 4.3% above its estimated fair value. The current EV-to-FCF is 7.74, which is 16% above median its 10-year median of 6.66 and 67.3% below the Medical Devices & Instruments industry median of 23.70. Concord Medical Co's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Concord Medical Co (ROCO:6518), the current EV-to-FCF is 7.74 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Concord Medical Co (ROCO:6518) Overvalued in 2026?
Based on GuruFocus' analysis, Concord Medical Co stock appears to be overvalued.
The current stock price of NT$30.40 is trading 4.3% above its estimated GF Value™ of NT$29.15.
GuruFocus considers Concord Medical Co to be Fairly Valued.
Key valuation signals for ROCO:6518:
EV-to-FCF: 7.74 (16% above median its 10-year median of 6.66)
GF Value™: NT$29.15 vs. price of NT$30.40 (4.3% above fair value)
Industry Position: 67.3% below the Medical Devices & Instruments median (#57 of 417)
No single metric tells the full story. See the ROCO:6518 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Concord Medical Co Ltd is a Taiwan based company involved in providing hospital management support services including medical equipment leasing, pharmaceuticals, and medical consumables integrated supply. . The company's main business items are medical equipment, pharmaceuticals Product trading business, leasing business and management consulting services.
71GF Score
Get the complete analysis for ROCO:6518
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6518 has been successfully added to your 
